相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Global Genomic and Proteomic Analysis Identified Critical Pathways Modulated by Proto-Oncogene PELP1 in TNBC
Zexuan Liu et al.
CANCERS (2022)
A First-in-Class Inhibitor of ER Coregulator PELP1 Targets ER plus Breast Cancer
Kristin A. Altwegg et al.
CANCER RESEARCH (2022)
Cryo-EM reveals the architecture of the PELP1-WDR18 molecular scaffold
Jacob Gordon et al.
NATURE COMMUNICATIONS (2022)
Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries
Hyuna Sung et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2021)
EC359: A First-in-Class Small-Molecule Inhibitor for Targeting Oncogenic LIFR Signaling in Triple-Negative Breast Cancer
Suryavathi Viswanadhapalli et al.
MOLECULAR CANCER THERAPEUTICS (2019)
Estrogen receptor coregulator binding modulator (ERX-11) enhances the activity of CDK4/6 inhibitors against estrogen receptor-positive breast cancers
Suryavathi Viswanadhapalli et al.
BREAST CANCER RESEARCH (2019)
PELP1: Structure, biological function and clinical significance
Gangadhara Reddy Sareddy et al.
GENE (2016)
The AAA ATPase MDN1 Acts as a SUMO-Targeted Regulator in Mammalian Pre-ribosome Remodeling
Nithya Raman et al.
MOLECULAR CELL (2016)
Triple-negative breast cancer: challenges and opportunities of a heterogeneous disease
Giampaolo Bianchini et al.
NATURE REVIEWS CLINICAL ONCOLOGY (2016)
Prognostic significance of proline, glutamic acid, leucine rich protein 1 (PELP1) in triple-negative breast cancer: a retrospective study on 129 cases
Yanzhi Zhang et al.
BMC CANCER (2015)
Novel role of PELP1 in regulating chemotherapy response in mutant p53-expressing triple negative breast cancer cells
Samaya R. Krishnan et al.
BREAST CANCER RESEARCH AND TREATMENT (2015)
Significantly increased PELP1 protein expression in primary and metastatic triple-negative breast carcinoma: comparison with GATA3 expression and PELP1's potential role in triple-negative breast carcinoma
Daniel N. Dang et al.
HUMAN PATHOLOGY (2015)
Minireview: Deciphering the Cellular Functions of PELP1
Preethi Ravindranathan et al.
MOLECULAR ENDOCRINOLOGY (2015)
PELP1: A review of PELP1 interactions, signaling, and biology
Brian J. Girard et al.
MOLECULAR AND CELLULAR ENDOCRINOLOGY (2014)
Significance of PELP1/HDAC2/miR-200 regulatory network in EMT and metastasis of breast cancer
S. S. Roy et al.
ONCOGENE (2014)
LAS1L interacts with the mammalian Rix1 complex to regulate ribosome biogenesis
Christopher D. Castle et al.
MOLECULAR BIOLOGY OF THE CELL (2012)
Significance of PELP1 in ER-Negative Breast Cancer Metastasis
Sudipa Roy et al.
MOLECULAR CANCER RESEARCH (2012)
Comprehensive molecular portraits of human breast tumours
Daniel C. Koboldt et al.
NATURE (2012)
Targeting the PELP1-KDM1 axis as a potential therapeutic strategy for breast cancer
Valerie Cortez et al.
BREAST CANCER RESEARCH (2012)
Significance of ER-Src axis in hormonal therapy resistance
Sreeram Vallabhaneni et al.
BREAST CANCER RESEARCH AND TREATMENT (2011)
Regulation of rDNA Transcription by Proto-Oncogene PELP1
Vijay K. Gonugunta et al.
PLOS ONE (2011)
Roscovitine confers tumor suppressive effect on therapy-resistant breast tumor cells
Binoj C. Nair et al.
BREAST CANCER RESEARCH (2011)
The prognostic significance of PELP1 expression in invasive breast cancer with emphasis on the ER-positive luminal-like subtype
Hany Onsy Habashy et al.
BREAST CANCER RESEARCH AND TREATMENT (2010)
Cyclin-Dependent Kinase-Mediated Phosphorylation Plays a Critical Role in the Oncogenic Functions of PELP1
Binoj C. Nair et al.
CANCER RESEARCH (2010)
PELP1: A Novel Therapeutic Target for Hormonal Cancers
Dimple Chakravarty et al.
IUBMB LIFE (2010)
Triple-negative breast cancer: disease entity or title of convenience?
Lisa Carey et al.
NATURE REVIEWS CLINICAL ONCOLOGY (2010)
Triple-Negative Breast Cancer
William D. Foulkes et al.
NEW ENGLAND JOURNAL OF MEDICINE (2010)
Oncogenic potential of the nuclear receptor coregulator proline-, glutamic acid-, leucine-rich protein 1/modulator of the nongenomic actions of the estrogen receptor
Rajib Rajhans et al.
CANCER RESEARCH (2007)
分享论文
